Telmo Llanga

Statistics

Publications

Citations

386

H-Index

Active since

2016

Affiliations

University of North Carolina at Chapel Hill(Current)

North Carolina State University

Duke University

Hunan Normal University

UNC Lineberger Comprehensive Cancer Center

Telmo Llanga is an author at University of North Carolina at Chapel Hill specializing in adeno-associated viral vectors, gene therapy, and ocular gene delivery.

Publications per year

2016–2023

Publications

DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists

Ibtehaj A. Naqvi, Nicholas Giroux, Lyra B. Olson et al. · Biomaterials · 2022 · 75 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Structure-Based Designed Nano-Dysferlin Significantly Improves Dysferlinopathy in BLA/J Mice

Telmo Llanga, Nadia Nagy, Laura Conatser et al. · Molecular Therapy · 2017 · 64 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

AAV Gene Therapy for MPS1-associated Corneal Blindness

Melisa Vance, Telmo Llanga, William C Bennett et al. · Scientific Reports · 2016 · 50 citations · Full text

Medicine, Biotechnology, Ophthalmology +15

Serotype survey of AAV gene delivery via subconjunctival injection in mice

Liujiang Song, Telmo Llanga, Laura Conatser et al. · Gene Therapy · 2018 · 49 citations · Full text

Pharmacy, Genetics, Pharmaceutics +16

Intrastromal Gene Therapy Prevents and Reverses Advanced Corneal Clouding in a Canine Model of Mucopolysaccharidosis I

Keiko Miyadera, Laura Conatser, Telmo Llanga et al. · Molecular Therapy · 2020 · 34 citations · Full text

Medicine, Ophthalmology, Veterinary Ophthalmology +17

1–5 of 11